Effectiveness and Safety of Princess FILLER Lidocaine in Correction of Nasolabial Folds (NLF) — FILIDO  

Dermatological Non-Disease Clinical Trial

Official title: A Randomized, Subject- and Evaluating Investigator-blinded, Controlled, Multicenter, Split-face, Comparison Clinical Investigation to Evaluate Effectiveness and Safety of Princess FILLER Lidocaine in the Correction of Nasolabial Folds

Status Completed

Clinical Trial Summary

Clinical Investigation to demonstrate the effectiveness and safety of Princess Filler Lidocaine in the correction of moderate to severe nasolabial folds

Clinical Trial Description

Clinical Investigation to assess the effectiveness of "Princess Filler Lidocaine" in reducing the severity of nasolabial folds compared to "Juvederm Ultra XC", based on the independent blinded evaluating investigator live assessment using the Nasolabial Folds Severity Rating Scale (NLF-SRS) at Week 24 after initial treatment and relative to Baseline assessments ;

Related Conditions & MeSH terms

• Dermatological Non-Disease

• NCT number: NCT03990883
• Study type: Interventional
• Source: Croma-Pharma GmbH
• Status: Completed
• Phase: N/A
• Start date: June 4, 2019
• Completion date: February 15, 2022